SM
TTHI

Sabby Management’s TRANSITION THERAPEUTICS INC (CANADA) TTHI Stock Holding History

Sabby Management’s Portfolio TTHI Stock Details TTHI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-64,500
Closed -$124K – 410
2015
Q4 		$124K Sell
64,500
-318,100
-83% -$604K 0.01% 295
2015
Q3 		$685K Buy
382,600
+79,763
+26% +$170K 0.03% 273
2015
Q2 		$636K Buy
302,837
+34,437
+13% +$241K 0.02% 246
2015
Q1 		$1.83M Buy
+268,400
New +$1.85M 0.08% 154

Other funds holding TTHI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
HCM
Hollencrest Capital Management Newport Beach, California $2.7B AUM 23.62% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
NC
NBW Capital Boston, Massachusetts $464M AUM 21.25% 1-Year Est. Return
VC
Vestor Capital Chicago, Illinois $1.59M AUM 51.04% 1-Year Est. Return

Sabby Management's TTHI Position: Q1 2016 in Review

Sabby Management sold out of TRANSITION THERAPEUTICS INC (CANADA) (TTHI) in Q1 2016, closing a stake of 64,500 shares — an estimated $124K sold.

Sabby Management first reported a position in TTHI in Q1 2015 and held it in 4 quarters. The position peaked at $1.83M in Q1 2015. 22 funds tracked by Wall St. Rank hold TTHI as of Q1 2016.

  • Sabby Management reported no remaining TRANSITION THERAPEUTICS INC (CANADA) position as of Q1 2016 after selling out during the quarter.
  • Sabby Management sold 64,500 TRANSITION THERAPEUTICS INC (CANADA) shares in Q1 2016, an estimated $124K.
  • Sabby Management first reported a position in TRANSITION THERAPEUTICS INC (CANADA) in Q1 2015 and held it in 4 quarters.
  • Sabby Management's TRANSITION THERAPEUTICS INC (CANADA) position peaked at $1.83M in Q1 2015.
  • 22 funds tracked by Wall St. Rank held TRANSITION THERAPEUTICS INC (CANADA) as of Q1 2016.

Based on Sabby Management's 13F filing for Q1 2016, filed 13 May 2016.